Iovance Biotherapeutics I... (IOVA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

8.03

2.61%

After-hours Dec 13, 2024, 07:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08
Revenue	1.19M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	10.76M	21.14M	13.98M	8.71M	8.12M	956.00K	952.00K	978.00K	999.00K	9.34M	4.66M	6.48M	19.30M	-	-	-
Gross Profit	-9.57M	-21.14M	-13.98M	-8.71M	-8.12M	-956.00K	-952.00K	-978.00K	-999.00K	-9.34M	-4.66M	-6.48M	-19.30M	-	-	-
Operating Income	-460.56M	-398.88M	-342.70M	-261.94M	-206.87M	-128.26M	-92.88M	-53.64M	-27.86M	-12.04M	-22.64M	-8.13M	-21.22M	-815.41K	-15.77K	-57.14K
Interest Income	13.04M	2.98M	451.00K	2.36M	9.32M	-	813.00K	745.00K	200.00K	-	-	-	-	-	-	-
Pretax Income	-447.52M	-395.89M	-342.25M	-259.58M	-197.56M	-123.58M	-92.06M	-52.89M	-27.66M	-12.03M	-25.38M	-3.31M	-25.69M	-1.61M	-15.77K	-57.14K
Net Income	-444.04M	-389.92M	-327.82M	-257.23M	-187.07M	-123.58M	-92.06M	-52.89M	-27.66M	-12.03M	-25.38M	-3.31M	-25.69M	-1.61M	-15.77K	-57.14K
Selling & General & Admin	106.92M	104.10M	83.66M	60.21M	40.85M	28.43M	21.26M	25.60M	12.39M	9.34M	4.66M	6.48M	19.30M	-	14.44K	25.56K
Research & Development	344.08M	294.78M	259.04M	201.73M	166.02M	99.83M	71.61M	28.04M	15.47M	2.70M	1.33M	1.66M	1.76M	-	-	-
Other Expenses	-	-	-	-	-	-	-	-	-	-	16.66M	-	19.30M	815.41K	15.77K	57.14K
Operating Expenses	450.99M	398.88M	342.70M	261.94M	206.87M	128.26M	92.88M	53.64M	27.86M	12.04M	22.64M	8.13M	21.06M	815.41K	15.77K	57.14K
Interest Expense	-	2.98M	-	-	-	-	-	-	200.00K	5.66K	444.73K	2.42M	151.51K	-	-	-
Selling & Marketing Expenses	79.22M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	461.75M	398.88M	342.70M	261.94M	206.87M	128.26M	92.88M	53.64M	27.86M	12.04M	22.64M	8.13M	21.06M	815.41K	15.77K	57.14K
Income Tax	-3.48M	-5.97M	-14.43M	-2.36M	-10.48M	4.68M	-952.00K	-978.00K	-999.00K	-	444.73K	2.42M	4.64M	792.58K	-	-
Shares Outstanding (Basic)	235.13M	159.26M	153.41M	138.30M	124.34M	97.28M	65.24M	55.27M	44.41M	24.99M	9.76M	798.53K	759.24K	652.46K	381.00K	1.21M
Shares Outstanding (Diluted)	235.13M	159.26M	153.41M	138.30M	124.34M	97.28M	65.24M	55.27M	44.41M	24.99M	9.76M	798.53K	759.24K	652.46K	381.00K	1.21M
EPS (Basic)	-1.89	-2.45	-2.14	-1.86	-1.5	-1.27	-1.41	-0.96	-0.62	-0.48	-2.6	-4.14	-33.84	-2.46	-0.04	-0.05
EPS (Diluted)	-1.89	-2.45	-2.14	-1.86	-1.5	-1.27	-1.41	-0.96	-0.62	-0.48	-2.6	-4.14	-33.84	-2.46	-0.04	-0.05
EBITDA	-427.43M	-374.76M	-328.27M	-250.87M	-189.43M	-122.62M	-91.11M	-51.92M	-26.66M	-11.95M	-24.93M	508.81K	-20.54M	-1.55M	-14.44K	-55.81K
Depreciation & Amortization	33.13M	21.14M	13.98M	8.71M	8.12M	956.00K	952.00K	978.00K	999.00K	88.22K	7.09K	6.21K	2.70K	58.60K	1.33K	1.33K